Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Small And Emerging Supplement Markets Offer Big Growth Opportunities

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement manufacturers eager to expand their international business should consider the potential of the small but rapidly growing markets in Eastern and Western Europe and emerging Asian markets (see chart: "1Top Global Markets in 2006")

You may also be interested in...

U.S.-Japan supplement groups collaborate

Representatives from the National Nutritional Foods Association of Japan and two U.S. supplement trade groups met in Tokyo June 6 to establish a working group to facilitate sharing regulatory and legislative information between the countries. The collaboration between NNFA-J, the Council for Responsible Nutrition and the Natural Products Association aims to increase Japanese consumers' access to supplements and foster trade between the U.S. and Japan, the groups say. NNFA-J plans to send a delegation to Washington to meet with CRN and NPA later this year. The groups plan to share information about regulations and legislation affecting issues including health claims, food safety and ingredients for food and supplement products...

J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores

J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.

Ensuring Leading Position For GSK Consumer Products Touted In Management Shift

GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts